FE Report
Trading of the shares of Orion Pharma will begin on the Dhaka Stock Exchange and Chittagong Stock Exchange tomorrow (Wednesday) under 'N' category, officials said.
Earlier on 6 March, the DSE board gave listing approval of the Orion Pharma at its board meeting. Orion Pharma is the 22th listed company in the Pharmaceuticals and Chemicals sector.
Using a fixed-price method, Orion Pharma floated 40 million ordinary shares of Tk 10 each at an offer price of Tk 60, including a premium of Tk 50.
The company's earnings-per share is Tk 5.57 and net asset value per share is Tk 76.86, according to its 2011 financial statements.
From 6-10th January Orion Pharma collected IPO application from resident Bangladeshi investors. NRB investors got 9 days more time to apply.
After finishing all process Initial Public Offering (IPO) lottery of Orion Pharma was held 7 February, 2013.
The Bangladesh Securities and Exchange Commission (BSEC) approved IPO prospectus of Orion Pharma 16 October last year.
Trading of the shares of Orion Pharma will begin on the Dhaka Stock Exchange and Chittagong Stock Exchange tomorrow (Wednesday) under 'N' category, officials said.
Earlier on 6 March, the DSE board gave listing approval of the Orion Pharma at its board meeting. Orion Pharma is the 22th listed company in the Pharmaceuticals and Chemicals sector.
Using a fixed-price method, Orion Pharma floated 40 million ordinary shares of Tk 10 each at an offer price of Tk 60, including a premium of Tk 50.
The company's earnings-per share is Tk 5.57 and net asset value per share is Tk 76.86, according to its 2011 financial statements.
From 6-10th January Orion Pharma collected IPO application from resident Bangladeshi investors. NRB investors got 9 days more time to apply.
After finishing all process Initial Public Offering (IPO) lottery of Orion Pharma was held 7 February, 2013.
The Bangladesh Securities and Exchange Commission (BSEC) approved IPO prospectus of Orion Pharma 16 October last year.
Blogger Comment
Facebook Comment